David Y. Johnson, MD

  • Assistant Consulting Professor
Department/Division
  • Interventional Radiology
  • Cardiothoracic Imaging
Address DUMC Box 3808
Durham, NC 27710
Telephone 919-684-7280
Fax 919-613-2680
Training
  • MD, St. Louis University, 2012
Residency
  • Diagnostic Radiology, Duke University Medical Center, 2017
Fellowship
  • Interventional Radiology, Duke University Medical Center, 2018
  • Johnson DY, Short RG, Patz EF Jr. Sequential CT Findings in Patients With Non-small-cell Lung Cancer Receiving Nivolumab. doi: 10.1016/j.cllc.2017.10.009. 2018 Mar;19(2):175-180 Abstract
  • Grimm LJ, Johnson DY, Johnson KS, Baker JA, Soo MS, Hwang ES, Ghate SV. Suspicious breast calcifications undergoing stereotactic biopsy in women ages 70 and over: Breast cancer incidence by BI-RADS descriptors. doi: 10.1007/s00330-016-4617-7. 2017 Jun;27(6):2275-2281 Abstract
  • Allam ES, Johnson DY, Grewal SG, Johnson FE. A sign on CT that predicts a hazardous ureteral anomaly. doi: 10.1016/j.ijscr.2016.03.029. 2016;22:51-4 Abstract
  • Rosenbloom MH, Tartaglia MC, Forner SA, Wong KK, Kuo A, Johnson DY, Colacurcio V, Andrews BD, Miller BL, DeArmond SJ, Geschwind MD. Metabolic disorders with clinical and radiologic features of sporadic Creutzfeldt-Jakob disease. 2015 Apr;5(2):108-115 Abstract
  • Geschwind MD, Kuo AL, Wong KS, Haman A, Devereux G, Raudabaugh BJ, Johnson DY, Torres-Chae CC, Finley R, Garcia P, Thai JN, Cheng HQ, Neuhaus JM, Forner SA, Duncan JL, Possin KL, Dearmond SJ, Prusiner SB, Miller BL. Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease. doi: 10.1212/WNL.0b013e3182a9f3b4. 2013 Dec 3;81(23):2015-23 Abstract
  • Johnson DY, Dunkelberger DL, Henry M, Haman A, Greicius MD, Wong K, DeArmond SJ, Miller BL, Gorno-Tempini ML, Geschwind MD. Sporadic Jakob-Creutzfeldt disease presenting as primary progressive aphasia. doi: 10.1001/2013.jamaneurol.139. 2013 Feb;70(2):254-7 Abstract
  • Paterson RW, Torres-Chae CC, Kuo AL, Ando T, Nguyen EA, Wong K, DeArmond SJ, Haman A, Garcia P, Johnson DY, Miller BL, Geschwind MD. Differential diagnosis of Jakob-Creutzfeldt disease. doi: 10.1001/2013.jamaneurol.79. 2012 Dec;69(12):1578-82 Abstract
  • Tartaglia MC, Johnson DY, Thai JN, Cattaruzza T, Wong K, Garcia P, Dearmond SJ, Miller BL, Geschwind MD. Clinical overlap between Jakob-Creutzfeldt disease and Lewy body disease. 2012 May;39(3):304-10. Abstract
  • Vitali P, Maccagnano E, Caverzasi E, Henry RG, Haman A, Torres-Chae C, Johnson DY, Miller BL, Geschwind MD. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. doi: 10.1212/WNL.0b013e31821a4439. 2011 May 17;76(20):1711-9 Abstract
  • Johnson DY, Johnson FE, Barner HB. Abdominal wall necrosis after harvest of both internal thoracic and inferior epigastric arteries. doi: 10.1016/j.athoracsur.2010.08.060. 2011 Jan;91(1):38-41 Abstract
  • Margenthaler JA, Meier JD, Virgo KS, Johnson DY, Goshima K, Chan D, Handler BS, Johnson FE. Geographic variation in posttreatment surveillance intensity for patients with cutaneous melanoma. 2003 Aug;186(2):194-200. Abstract
  • Margenthaler JA, Johnson DY, Virgo KS, Fosko SW, Chan D, Goshima K, Handler BS, Johnson FE. Evaluation of patients with clinically suspected melanoma recurrence: current practice patterns of plastic surgeons. 2002 Sep;21(3):591-6. Abstract
  • Margenthaler JA, Virgo KS, Johnson DY, Sugarbaker EM, Handler BS, Johnson FE. How surgeon age affects post-treatment surveillance strategies for melanoma patients. 2001 Jul;19(1):175-80. Abstract
  • Johnson FE, Virgo KS, Johnson DY, Chan D, Goshima K, Handler BS. Effect of initial tumor stage on patient follow-up after potentially curative surgery for cutaneous melanoma. 2001 May;18(5):973-8. Abstract
  • Virgo KS, Chan D, Handler BS, Johnson DY, Goshima K, Johnson FE. Current practice of patient follow-up after potentially curative resection of cutaneous melanoma. 2000 Sep;106(3):590-7. Abstract